Bouygues SA (EN)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 40.30 |
|---|---|
| 52-week range | 38.53 – 53.48 |
| Return, 1 month / 3 months | −6.8% / −15.7% |
| Return, 1 year / 3 years | +1.3% / +48.6% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 21.1% |
| Worst drawdown (1 year) | -24.3% |
| Average daily value traded | 29.10M EUR |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bouygues is a French industrial group based in Paris. Its construction arm builds and renovates buildings and civil engineering works, while its Colas subsidiary specialises in roads and transport infrastructure. The group also runs a telecoms operator serving mobile and broadband customers in France, and holds a media business that produces and broadcasts television content. Its customers range from public authorities and private developers to households and businesses, and its operations span France and international markets.
On this site Bouygues SA appears as a stock on the Euronext Paris (France), code EN, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bouygues SA (EN) trades on the Euronext Paris in France. It last closed at EUR 40.30 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 187 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.3% and over the last three months it fell 15.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -14.3% | ||
| From 52-week high | -24.0% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.7% | ||
| 6-month return | -20.0% | ||
| 12-month return, skipping the last month | 8.7% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.3% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 29.10M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.9% |
|---|---|
| 1 month | −6.8% |
| 3 months | −15.7% |
| 6 months | −20.0% |
| 1 year | +1.3% |
| 3 years | +48.6% |
| 5 years | +52.2% |
Signals
| 50-day / 200-day average | 43.15 / 47.00 |
|---|---|
| Golden / death cross (60 days) | Death, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2026 | EUR 2.1000 |
| 5 May 2025 | EUR 2.0000 |
| 30 Apr 2024 | EUR 1.9000 |
| 3 May 2023 | EUR 1.8000 |
| 3 May 2022 | EUR 1.8000 |
| 4 May 2021 | EUR 1.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.